EPROGNOX TECH (UK) LTD

Executive Summary

EPROGNOX TECH (UK) LTD is a newly formed dormant company with minimal financial activity and net assets of £1, indicating no current trading operations. The company is financially stable but inactive, with future financial health dependent on commencing business activities and generating revenue. Compliance with filing requirements is up to date, providing a solid foundation for the company’s planned operational launch.

EPROGNOX TECH (UK) LTD - Analysis Report

Company Number: 15428370

Analysis Date: 2025-07-19 12:32 UTC

Financial Health Assessment for EPROGNOX TECH (UK) LTD

---

1. Financial Health Score: D

Explanation:
This company is newly incorporated and classified as dormant, with minimal financial activity and net assets of just £1. While it meets the legal requirements for dormant status, the lack of operational activity and financial transactions limits the ability to assess active business health. The financial "vital signs" are minimal, indicating a "baseline" or inactive state rather than a robust or growing business.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active	Legally registered and operational, but dormant financially.
Account Category	Dormant	No significant financial transactions or trading activity.
Net Assets	£1	Minimal equity; indicates no business assets or retained capital.
Shareholders' Funds	£1	Same as net assets; reflects initial issued share capital only.
Financial History	N/A	No trading history or profit & loss data available yet.
Director & PSC	Single director with 75-100% control	Centralised control, typical of small/startup companies.
Industry Classification (SIC)	Engineering consultancy, IT consultancy, software development	Business activities identified but not yet operational.

Interpretation:
The company shows the "symptom" of dormancy—a lack of financial activity and operational trading. This resembles a patient in a "resting" state, with no evident stress or strain but also no vitality or growth signs. The balance sheet is minimal, showing only the nominal share capital, which is typical for a dormant company.

---

3. Diagnosis

EPROGNOX TECH (UK) LTD is currently in a dormant state, having been incorporated recently in January 2024 and not engaged in any trading activity or financial transactions as of the latest accounts dated January 2025. This means the company has no revenues, expenses, or operational cash flows to evaluate. The financial condition is stable in the sense that there are no liabilities or losses, but it is not yet an active, revenue-generating business.

This dormant status may be intentional, often used for reserving the company name, preparing for future trading, or holding intellectual property. The company’s financial "vital signs" indicate no distress; the symptoms show it has not yet started its business operations.

---

4. Recommendations

• Activate Trading Operations When Ready: To move from dormant to healthy operational status, the company should begin its planned business activities. This will generate financial data for a fuller health assessment.
• Maintain Compliance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties.
• Build Capital and Assets: Once active, consider capital injections or asset acquisitions to strengthen net assets and working capital.
• Monitor Cash Flow: Upon trading, maintain healthy cash flow management to avoid liquidity issues.
• Prepare Financial Records: Ensure proper accounting systems are in place to record transactions and produce accurate financial statements.
• Strategic Planning: Develop a business plan aligned with the SIC codes (engineering, IT consultancy, software development) to guide growth and investment.

---

Summary

EPROGNOX TECH (UK) LTD is currently in a dormant phase with minimal financial activity and net assets of £1, reflecting its status as a newly incorporated entity without trading operations. While there are no signs of financial distress, the company’s financial health cannot be fully assessed until it begins active trading. Maintaining compliance and preparing for operational start-up will be critical next steps towards establishing a healthy financial position.